(Bloomberg) -- Eli Lilly & Co. has surged about 300% since its first GLP-1 was approved over four years ago, propelling it past $1 trillion in market value and making it the world's most valuable pharmaceutical company. Most Read from Bloomberg Zuckerberg Has an AI Empire to Build. Meet the Adviser Who Handles the Details Fed Raises Rates to Curb Inflation, Drawing Rebuke From Trump Stocks, Bonds Rise After Fed-Day Drop as Oil Falls: Markets Wrap Jobless Tech Workers Are Being Left Out of San Francisco's AI Boom Warsh Defies Trump's Calls for Rate Cut as War Stokes Inflation The stock's newest bull on Wall Street, Berenberg's Kerry Holford, says the rally is just getting started.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.